Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Tuesday, December 31, 2024.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2024 (2024-12-31): 773.06%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
255.29%
RETURN ON EQUITY (ROE) AVG 3Y
103.60%
RETURN ON EQUITY (ROE) AVG 5Y
84.44%
RETURN ON EQUITY (ROE) AVG 10Y
43.93%
RETURN ON EQUITY (ROE) AVG 15Y
28.01%
RETURN ON EQUITY (ROE) AVG 20Y
23.63%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
DaVita Inc.
Market Cap
$11.66B
Return on Equity (ROE)
N/A
TTM Avg
255.29%
3Y Avg
103.60%
5Y Avg
84.44%
Market Cap
$11.29B
Return on Equity (ROE)
8.63%
TTM Avg
6.23%
3Y Avg
8.78%
5Y Avg
10.01%
Market Cap
$12.07B
Return on Equity (ROE)
23.91%
TTM Avg
22.63%
3Y Avg
21.83%
5Y Avg
21.13%
Market Cap
$12.30B
Return on Equity (ROE)
-17.13%
TTM Avg
-12.46%
3Y Avg
-8.76%
5Y Avg
-1.37%
Market Cap
$10.80B
Return on Equity (ROE)
9.77%
TTM Avg
10.54%
3Y Avg
10.84%
5Y Avg
19.93%
Market Cap
$12.52B
Return on Equity (ROE)
10.49%
TTM Avg
6.83%
3Y Avg
5.29%
5Y Avg
3.21%
Market Cap
$10.66B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.58B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.51B
Return on Equity (ROE)
6.85%
TTM Avg
4.70%
3Y Avg
4.67%
5Y Avg
11.22%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DaVita Inc. (DVA) | $11.66B | N/A | 255.29% | 103.60% | 84.44% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 8.63% | 6.23% | 8.78% | 10.01% |
| Encompass Health Corporation (EHC)vs › | $12.07B | 23.91% | 22.63% | 21.83% | 21.13% |
| Baxter International Inc. (BAX)vs › | $12.30B | -17.13% | -12.46% | -8.76% | -1.37% |
| Align Technology, Inc. (ALGN)vs › | $10.80B | 9.77% | 10.54% | 10.84% | 19.93% |
| Penumbra, Inc. (PEN)vs › | $12.52B | 10.49% | 6.83% | 5.29% | 3.21% |
| Molina Healthcare, Inc. (MOH)vs › | $10.66B | -0.17% | 18.91% | 22.60% | 24.60% |
| Universal Health Services, Inc. (UHS)vs › | $10.58B | 20.31% | 18.80% | 15.17% | 15.31% |
| The Cooper Companies, Inc. (COO)vs › | $10.51B | 6.85% | 4.70% | 4.67% | 11.22% |
| Tempus AI, Inc. (TEM)vs › | $10.34B | -57.18% | -651.33% | -315.37% | -198.08% |
ROE
N/A
ROA
4.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2024-12-31 | 773.06% |
| 2024-09-30 | 214.03% |
| 2024-06-30 | 135.82% |
| 2024-03-31 | 88.08% |
| 2023-12-31 | 65.48% |
| 2023-09-30 | 50.78% |
| 2023-06-30 | 45.97% |
| 2023-03-31 | 62.25% |
| 2022-12-31 | 78.67% |
| 2022-09-30 | 127.62% |
| 2022-06-30 | 137.93% |
| 2022-03-31 | 107.04% |
| 2021-12-31 | 129.51% |
| 2021-09-30 | 83.93% |
| 2021-06-30 | 67.59% |
| 2021-03-31 | 61.81% |
| 2020-12-31 | 55.92% |
| 2020-09-30 | 53.64% |
| 2020-06-30 | 38.50% |
| 2020-03-31 | 46.27% |
| 2019-12-31 | 38.01% |
| 2019-09-30 | 17.96% |
| 2019-06-30 | 3.37% |
| 2019-03-31 | 3.35% |
| 2018-12-31 | 4.30% |
| 2018-09-30 | 16.02% |
| 2018-06-30 | 12.50% |
| 2018-03-31 | 8.61% |
| 2017-12-31 | 14.15% |
| 2017-09-30 | 10.83% |
| 2017-06-30 | 25.64% |
| 2017-03-31 | 23.93% |
| 2016-12-31 | 18.93% |
| 2016-09-30 | 14.58% |
| 2016-06-30 | 7.60% |
| 2016-03-31 | 10.16% |
| 2015-12-31 | 5.54% |
| 2015-09-30 | 9.69% |
| 2015-06-30 | 8.78% |
| 2015-03-31 | 8.63% |
| 2014-12-31 | 13.99% |
| 2014-09-30 | 14.62% |
| 2014-06-30 | 14.21% |
| 2014-03-31 | 16.88% |
| 2013-12-31 | 14.29% |
| 2013-09-30 | 13.52% |
| 2013-06-30 | 14.18% |
| 2013-03-31 | 11.21% |
| 2012-12-31 | 14.24% |
| 2012-09-30 | 20.82% |
| 2012-06-30 | 21.82% |
| 2012-03-31 | 23.02% |
| 2011-12-31 | 22.33% |
| 2011-09-30 | 19.95% |
| 2011-06-30 | 20.36% |
| 2011-03-31 | 18.84% |
| 2010-12-31 | 20.51% |
| 2010-09-30 | 19.23% |
| 2010-06-30 | 19.03% |
| 2010-03-31 | 19.28% |
| 2009-12-31 | 19.80% |
| 2009-09-30 | 19.81% |
| 2009-06-30 | 19.71% |
| 2009-03-31 | 20.55% |
| 2008-12-31 | 19.16% |
| 2008-09-30 | 18.96% |
| 2008-06-30 | 20.34% |
| 2008-03-31 | 21.81% |
| 2007-12-31 | 22.04% |
| 2007-09-30 | 22.75% |
| 2007-06-30 | 24.70% |
| 2007-03-31 | 22.80% |
| 2006-12-31 | 23.25% |
| 2006-09-30 | 24.39% |
| 2006-06-30 | 23.02% |
| 2006-03-31 | 23.87% |
| 2005-12-31 | 26.88% |
| 2005-09-30 | 28.62% |
| 2005-06-30 | 32.94% |
| 2005-03-31 | 36.50% |
| 2004-12-31 | 42.49% |
| 2004-09-30 | 50.50% |
| 2004-06-30 | 43.74% |
| 2004-03-31 | 49.19% |
| 2003-12-31 | 57.28% |
| 2003-09-30 | 68.53% |
| 2003-06-30 | 118.43% |
